Integrity Alliance LLC. purchased a new position in Cameco Corporation (NYSE:CCJ – Free Report) (TSE:CCO) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 8,814 shares of the basic materials company’s stock, valued at approximately $806,000.
Several other hedge funds have also recently modified their holdings of CCJ. Nisa Investment Advisors LLC purchased a new stake in shares of Cameco in the 4th quarter worth approximately $25,000. Founders Capital Management bought a new position in Cameco in the fourth quarter worth about $27,000. Strategic Advocates LLC bought a new position in Cameco in the third quarter worth about $28,000. Sunbelt Securities Inc. raised its holdings in Cameco by 928.6% in the third quarter. Sunbelt Securities Inc. now owns 360 shares of the basic materials company’s stock worth $30,000 after purchasing an additional 325 shares in the last quarter. Finally, Delos Wealth Advisors LLC raised its holdings in Cameco by 60.0% in the third quarter. Delos Wealth Advisors LLC now owns 400 shares of the basic materials company’s stock worth $34,000 after purchasing an additional 150 shares in the last quarter. Hedge funds and other institutional investors own 70.21% of the company’s stock.
Cameco Trading Up 3.2%
NYSE CCJ opened at $110.83 on Friday. The company has a fifty day simple moving average of $112.93 and a two-hundred day simple moving average of $107.62. The stock has a market cap of $48.27 billion, a P/E ratio of 102.62, a P/E/G ratio of 1.81 and a beta of 1.04. Cameco Corporation has a 12-month low of $57.63 and a 12-month high of $135.24. The company has a current ratio of 3.08, a quick ratio of 2.09 and a debt-to-equity ratio of 0.14.
Analyst Ratings Changes
A number of equities analysts have commented on CCJ shares. William Blair started coverage on shares of Cameco in a report on Monday, April 20th. They issued an “outperform” rating for the company. Zacks Research downgraded shares of Cameco from a “strong-buy” rating to a “hold” rating in a report on Wednesday, February 18th. Sanford C. Bernstein reiterated an “outperform” rating and issued a $147.00 target price on shares of Cameco in a report on Thursday, February 5th. TD Securities downgraded shares of Cameco from a “strong-buy” rating to a “hold” rating in a report on Thursday, March 26th. Finally, Canadian Imperial Bank of Commerce boosted their target price on shares of Cameco to $202.00 in a report on Monday, March 9th. Eleven investment analysts have rated the stock with a Buy rating and five have given a Hold rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $148.62.
Get Our Latest Research Report on CCJ
Cameco Company Profile
Cameco Corporation (NYSE: CCJ) is a leading producer of uranium and a supplier to the global nuclear power industry. Headquartered in Saskatoon, Saskatchewan, Canada, the company is engaged in the exploration, mining, milling and sale of uranium concentrate, commonly known as yellowcake, which is used as fuel for nuclear reactors. Cameco also participates in services and activities that support the front end of the nuclear fuel cycle, including processing and marketing of uranium to utilities under long‑term and spot contracts.
The company’s operations have historically centered in Canada and the United States, where it operates and develops uranium mining and processing properties.
See Also
- Five stocks we like better than Cameco
- 3 Stocks Rallying on Micron’s Price Boost: Substance or Hype?
- Snowflake and the Snowballing Impact of its AI Flywheel
- AI’s Biggest Bottleneck Could Make These 2 Stocks Soar
- These 3 Beaten-Down Stocks Just Saw $25 Million in Insider Buying
Receive News & Ratings for Cameco Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cameco and related companies with MarketBeat.com's FREE daily email newsletter.
